2009至2015年欧洲旅行相关甲型肝炎
该研究利用13个欧盟/欧洲经济区国家的甲型肝炎监测数据和旅行分母数据,估计欧洲旅行者甲型肝炎风险。2009至2015年13国报告18,839例确诊病例,其中5,233例(27.8%)为旅行相关,39.8%为15岁以下儿童;旅行相关风险以年均3.7%下降,2009年0.70例/百万夜降至2015年0.51例/百万夜;前往非洲的旅行者风险最高(2.11例/百万夜)。作者认为旅行仍是EU/EEA甲型肝炎感染的主要风险因素,15岁以下儿童应优先接种疫苗。
要点
- 2009至2015年13个EU/EEA国家报告18,839例甲型肝炎确诊病例,其中5,233例(27.8%)为旅行相关。
- 旅行相关病例中39.8%为15岁以下儿童。
- 旅行相关甲型肝炎风险以年均3.7%下降,2009年0.70例/百万夜降至2015年0.51例/百万夜。
核心结论
- 旅行仍是EU/EEA甲型肝炎病毒感染的主要风险因素,尽管近年感染风险可能略有下降。
- 15岁以下儿童占旅行相关病例的很大比例,应优先接种疫苗。
研究设计与样本
- 研究从13个具有全面监测系统的欧盟/欧洲经济区国家获取甲型肝炎监测数据,并从欧盟统计局获取旅行分母数据。
- 旅行相关甲型肝炎病例定义为任何报告为输入性的病例。
- 研究估计了欧洲旅行者甲型肝炎风险,使用监测和旅行分母数据。
主要发现
- 2009至2015年,13个国家报告18,839例甲型肝炎确诊病例,其中5,233例(27.8%)为旅行相关。
- 旅行相关病例中39.8%为15岁以下儿童。
- 旅行相关风险以年均3.7%(95%CI:0.7-2.7)下降,从2009年0.70例/百万夜降至2015年0.51例/百万夜。
- 前往非洲的旅行者风险最高(2.11例/百万夜)。
- 更可能报告为旅行相关的病例为男性和年轻年龄(<25岁)。
关键数值与推荐
- 旅行相关甲型肝炎病例定义为任何报告为输入性的病例。
- 高风险旅行目的地为非洲(2.11例/百万夜)。
- 旅行相关风险年下降率为3.7%(95%CI:0.7-2.7)。
临床怎么用
- 作者认为15岁以下儿童应优先接种疫苗。
- 原文未据此给出其他推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BackgroundTravel to countries with high or intermediate hepatitis A virus (HAV) endemicity is a risk factor for infection in residents of countries with low HAV endemicity. Aim: The objective of this study was to estimate the risk for hepatitis A among European travellers using surveillance and travel denominator data. Methods: We retrieved hepatitis A surveillance data from 13 European Union (EU)/ European Economic Area (EEA) countries with comprehensive surveillance systems and travel denominator data from the Statistical Office of the European Union. A travel-associated case of hepatitis A was defined as any case reported as imported. Results: From 2009 to 2015, the 13 countries reported 18,839 confirmed cases of hepatitis A, of which 5,233 (27.8%) were travel-associated. Of these, 39.8% were among children younger than 15 years. The overall risk associated with travel abroad decreased over the period at an annual rate of 3.7% (95% confidence interval (CI): 0.7-2.7) from 0.70 cases per million nights in 2009 to 0.51 in 2015. The highest risk was observed in travellers to Africa (2.11 cases per million nights). Cases more likely to be reported as travel-associated were male and of younger age (< 25 years). Conclusion: Travel is still a major risk factor for HAV infection in the EU/EEA, although the risk of infection may have slightly decreased in recent years. Children younger than 15 years accounted for a large proportion of cases and should be prioritised for vaccination.
引用
- Beauté J, Westrell T, Schmid D, et al. Travel-associated hepatitis A in Europe, 2009 to 2015. Euro Surveill. 2018. PMID: 29871720. doi:10.2807/1560-7917.ES.2018.23.22.1700583
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。